Ciprofloxacin for BK Viremia Prophylaxis in Kidney Transplant Recipients: Results of a Prospective, Randomized Controlled Trial.

被引:0
|
作者
Patel, S. [1 ]
Kuten, S. [1 ]
Knight, R. [1 ]
Nolte, J. [1 ]
Nguyen, D. [1 ]
Graviss, E. [1 ]
Moore, L. [1 ]
Agboli, I. [1 ]
Pham, C. [1 ]
Gaber, A. [1 ]
机构
[1] Houston Methodist Hosp, Houston, TX USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
135
引用
收藏
页码:299 / 299
页数:1
相关论文
共 50 条
  • [21] Pharmacoeconomic Impact of Valganciclovir Versus Valacyclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients: A Randomized Controlled Trial.
    Kacer, M.
    Kielberger, L.
    Bouda, M.
    Reischig, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 763 - 763
  • [22] Pharmacoeconomic Impact of Valganciclovir Versus Valacyclovir for Cytomegalovirus Prophylaxis in Renal Transplant Recipients: A Randomized Controlled Trial.
    Kacer, M.
    Kielberger, L.
    Bouda, M.
    Reischig, T.
    TRANSPLANTATION, 2014, 98 : 763 - 763
  • [23] Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients
    Abend, Johanna R.
    Changala, Marguerite
    Sathe, Atul
    Casey, Fergal
    Kistler, Amy
    Chandran, Sindhu
    Howard, Abigail
    Wojciechowski, David
    TRANSPLANTATION, 2017, 101 (06) : 1495 - 1505
  • [24] Valacyclovir or valganciclovir for cytomegalovirus prophylaxis: A randomized controlled trial in adult and pediatric kidney transplant recipients
    Verghese, Priya S.
    Evans, Michael D.
    Hanson, Amy
    Hathi, Justina
    Chinnakotla, Srinath
    Matas, Arthur
    Balfour Jr, Henry H.
    JOURNAL OF CLINICAL VIROLOGY, 2024, 172
  • [25] Ciprofloxacin Prophylaxis in Kidney Transplant Recipients Reduces BK Virus Infection at 3 Months But Not at 1 Year
    Wojciechowski, David
    Chanda, Ranjan
    Chandran, Sindhu
    Lee, Brian
    Webber, Allison
    Macaraig, Melanie
    Tomlanovich, Stephen
    Vincenti, Flavio
    TRANSPLANTATION, 2012, 94 (11) : 1117 - 1123
  • [26] Effectiveness and Tolerability of Cidofovir for the Management of BK Viremia in Kidney Transplant Recipients
    Thornberg, M.
    Hedvat, J.
    Lange, N.
    Brennan, C.
    Salerno, D.
    Tsapepas, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 820 - 821
  • [27] Leflunomide Therapy for Treatment of Bk Viremia in Pediatric Kidney Transplant Recipients
    Aldieri, A.
    Chandran, M.
    Matossian, D.
    Magella, B.
    Lazear, D.
    Bock, M.
    Blanchette, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 323 - 323
  • [28] BK Viremia Is Cleared More Slowly in Older Kidney Transplant Recipients
    Huang, Y.
    Luan, F.
    Kaul, D.
    Samaniego, M.
    TRANSPLANTATION, 2014, 98 : 86 - 86
  • [29] Leflunomide therapy for treatment of BK viremia in pediatric kidney transplant recipients
    Blanchette, Eliza
    Aldieri, Alexandra
    Chandran, Mary
    Bock, Margret
    Matossian, Debora
    Hariprasad, Aparna
    Magella, Bliss
    Lazear, Danielle
    PEDIATRIC TRANSPLANTATION, 2022, 26
  • [30] Induction Immunosuppression in Crossmatch Positive Renal Transplant Recipients: Results of a Randomized Controlled Clinical Trial.
    Locke, Jayme E.
    Simpkins, Christopher E.
    Leffell, Mary S.
    Zachary, Andrea A.
    Collins, Vanessa
    Warren, Daniel S.
    Segev, Dorry L.
    Singer, Andrew L.
    Haas, Mark
    Montgomery, Robert A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 241 - 241